Oaktree Capital Management »

Bridgebio Pharma shares owned by Oaktree Capital Management

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Oaktree Capital Management from 13F filings

Historical chart of Oaktree Capital Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Oaktree Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Oaktree Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.6M 1.9M 1.41
2025-06-30 $2.6M 2.1M 1.25
2025-03-31 $1.4M 1.3M 1.15
2024-09-30 $1.3M 1.2M 1.03
2024-03-31 $2.1M 2.0M 1.08

More positions owned by Oaktree Capital Management

Torm Common Stock (TRMD)
Expand Energy Corp Common Stock (EXE)
Garrett Motion Common Stock (GTX)
Anglogold Ashanti Common Stock (AU)
Viper Energy Common Stock (VNOM)
State Street Corp Etf Put Option (SPY)
Talen Energy Corp Common Stock Call Option (TLN)
Telephone And Data Systems Common Stock (TDS)
Oracle Corp Common Stock Put Option (ORCL)
Sunopta Common Stock (STKL)
Core Scientific Common Stock (CORZ)
Barrick Mining Corp Common Stock (B)
Liberty Global Common Stock (LBTYA)
Ftai Aviation Common Stock (FTAI)
Cemex Sab De Cv Common Stock (CX)

View all positions for Oaktree Capital Management

Top funds holding Bridgebio Pharma

Wolverine Asset Management
Linden Advisors
Weiss Asset Management LP[1
Tenor Capital Management
Citadel Advisors
Graham Capital Management
Balyasny Asset Management
Ing Investment Management
Capstone Investment Advisors
Lazard Asset Management
683 Capital Management
Lord, Abbett & Co
M&G
Morgan Stanley
State Street Corporation

View all funds holding Bridgebio Pharma